# US 2022/0031675 A1 · Methods for treating irritable bowel syndrome (ibs)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031675 A1
- Document ID: US20220031675A1
- Status: Published application
- Kind: A1
- Application number: 17/197,561
- Filed: 2021-03-10
- Published: 2022-02-03
- Earliest claimed: 2008-02-26
- Assignees: Salix Pharmaceuticals, Inc.
- Applicants: Salix Pharmaceuticals, Inc.
- Inventors: William Forbes; Enoch Bortey
- Web page: https://patentgrep.com/patent/US20220031675A1

## CPC

- A61K 31/437: the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides new methods and kits for treating IBS; treating IBS in females; treating IBS in older subjects; and treating IBS in non-white subjects.

## Claims

### Claim 1

A method of treating Irritable Bowel Syndrome (IBS), comprising:
administering 550 mg of rifaximin TID to a subject in need thereof,
thereby treating Irritable Bowel Syndrome (IBS).

### Claim 2 (depends on 1)

The method of claim 1, wherein the IBS is diarrhea-predominant IBS.

### Claim 3 (depends on 1)

The method of claim 1, wherein the IBS is alternating-predominant IBS.

### Claim 4 (depends on 1)

The method of claim 1, wherein a subject is administered rifaximin for between about 14 days and about 24 months.

### Claim 5 (depends on 1)

The method of claim 1, wherein treating IBS comprises treating one or more of IBS symptoms or the IBS symptom of bloating.

### Claim 6 (depends on 5)

The method of claim 5, wherein the treating one or more IBS symptoms is a reduction from baseline symptoms.

### Claim 7 (depends on 6)

The method of claim 6, wherein baseline symptoms are established prior to treatment.

### Claim 8 (depends on 6)

The method of claim 6, wherein adequate relief of IBS symptoms comprise a ‘yes’ response from a subject when asked the question comprising “In the past 7 days, have you had adequate relief of your symptom of your IBS symptoms?”

### Claim 9 (depends on 8)

The method of claim 8, wherein adequate relief of IBS symptoms comprises an affirmative response from a subject if asked whether they have had adequate relief of symptom of IBS.

### Claim 10 (depends on 1)

The method of claim 1, wherein IBS symptoms comprise one or more of cramping, pain, diarrhea, constipation, lumpy stool, watery stool, frequent stool production, abdominal pain, abdominal discomfort, urgency, or tenesmus.

### Claim 11 (depends on 5)

The method of claim 5, wherein adequate relief of bloating symptoms comprises a reduction of bloating symptoms.

### Claim 12 (depends on 11)

The method of claim 11, wherein the reduction in bloating symptoms is a reduction from baseline symptoms.

### Claim 13 (depends on 12)

The method of claim 12, wherein baseline symptoms are established prior to treatment.

### Claim 14 (depends on 13)

The method of claim 13, wherein adequate relief of bloating symptoms comprise a ‘yes’ response from a subject when asked a question, comprising “In the past 7 days, have you had adequate relief of your IBS symptom of bloating?”

### Claim 15 (depends on 14)

The method of claim 14, wherein adequate relief of IBS symptoms comprises an affirmative response from a subject if asked weather they have had adequate relief of the IBS symptom of bloating.

### Claim at position 16

16-18. (canceled)

### Claim 19

A method of treating IBS in older subjects comprising administering 550 mg of rifaximin TID to an older subject in need thereof, thereby treating IBS in older subjects.

### Claim at position 18

20-26. (canceled)

### Claim 27

A method of treating abdominal pain associated with Irritable Bowel Syndrome (IBS), comprising:
administering 550 mg of rifaximin TID to a subject in need thereof,
thereby treating abdominal pain Irritable Bowel Syndrome (IBS).

### Claim 28 (depends on 27)

The method of claim 27, wherein the IBS is diarrhea-predominant IBS.

### Claim 29 (depends on 27)

The method of claim 27, wherein the IBS is alternating-predominant IBS.

### Claim 30 (depends on 1)

The method of claim 1, wherein treating IBS comprises treating an IBS symptom of pain.

### Claim at position 23

31-36. (canceled)
